- Home
- SEV vs PRQR Comparison
SEV vs PRQR Comparison
Compare SEV & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEV
- PRQR
- Stock Information
- Founded
- SEV 2019
- PRQR 2012
- Country
- SEV United States
- PRQR Netherlands
- Employees
- SEV N/A
- PRQR N/A
- Industry
- SEV Auto Manufacturing
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- SEV Industrials
- PRQR Health Care
- Exchange
- SEV Nasdaq
- PRQR Nasdaq
- Market Cap
- SEV 189.2M
- PRQR 224.4M
- IPO Year
- SEV N/A
- PRQR 2014
- Fundamental
- Price
- SEV $7.34
- PRQR $2.80
- Analyst Decision
- SEV
- PRQR Strong Buy
- Analyst Count
- SEV 0
- PRQR 8
- Target Price
- SEV N/A
- PRQR $8.88
- AVG Volume (30 Days)
- SEV 1.4M
- PRQR 649.8K
- Earning Date
- SEV 01-01-0001
- PRQR 11-07-2025
- Dividend Yield
- SEV N/A
- PRQR N/A
- EPS Growth
- SEV N/A
- PRQR N/A
- EPS
- SEV N/A
- PRQR N/A
- Revenue
- SEV N/A
- PRQR $20,129,184.00
- Revenue This Year
- SEV N/A
- PRQR N/A
- Revenue Next Year
- SEV N/A
- PRQR N/A
- P/E Ratio
- SEV N/A
- PRQR N/A
- Revenue Growth
- SEV N/A
- PRQR 8.65
- 52 Week Low
- SEV $3.55
- PRQR $1.07
- 52 Week High
- SEV $22.43
- PRQR $4.21
- Technical
- Relative Strength Index (RSI)
- SEV N/A
- PRQR 60.30
- Support Level
- SEV N/A
- PRQR $2.71
- Resistance Level
- SEV N/A
- PRQR $3.00
- Average True Range (ATR)
- SEV 0.00
- PRQR 0.24
- MACD
- SEV 0.00
- PRQR 0.01
- Stochastic Oscillator
- SEV 0.00
- PRQR 71.11
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.